Concise review: The dynamics of induced pluripotency and its behavior captured in gene network motifs

Stem Cells

Volumn 31, Issue 5, 2013, Pages 838-848

  Muraro, Mauro J ^a   Kempe, Hermannus ^a   Verschure, Pernette J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Induced pluripotent stem cells; Network motifs; Reprogramming dynamics; Systems behavior

Indexed keywords

HISTONE H3; MICROSOMAL AMINOPEPTIDASE; MYC PROTEIN; THY 1 ANTIGEN; TRANSCRIPTION FACTOR SNAIL;

AUTOREGULATION; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CELL SHAPE; CELL SIZE; CELL STRUCTURE; DNA REPLICATION; DOWN REGULATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE REGULATORY NETWORK; GENE SILENCING; HISTONE MODIFICATION; INDUCED PLURIPOTENCY; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; REVIEW; SIGNAL TRANSDUCTION; SOMATIC CELL GENETICS; SYSTEMS BIOLOGY; TELOMERE ELONGATION; TELOMERE HOMEOSTASIS; TRANSGENE; X CHROMOSOME;

ANIMALS; CELL DIFFERENTIATION; GENE REGULATORY NETWORKS; HUMANS; INDUCED PLURIPOTENT STEM CELLS;

IPS;

EID: 84876513355     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1340     Document Type: Review

References (80)

1. Hanna J, Wernig M, Markoulaki S et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007;318:1920-1923.
2. Wernig M, Zhao J-P, Pruszak J et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA 2008;105:5856-5861. (Pubitemid 351758462)
3. Wu SM, Hochedlinger K. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol 2011;13:497-505.
4. Ellis J, Bhatia M. iPSC technology: Platform for drug discovery. Clin Pharmacol Ther 2011;89:639-641.
5. Maherali N, Sridharan R, Xie W et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007;1:55-70.
6. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007;448:313-317. (Pubitemid 47080336)
7. Wernig M, Meissner A, Foreman R et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007;448:318-324. (Pubitemid 47080337)
8. Bilic J, Izpisua Belmonte JC. Concise review: Induced pluripotent stem cells versus embryonic stem cells: Close enough or yet too far apart? Stem Cells 2012;30:33-41.
9. Zhao X, Li W, Lv Z et al. iPS cells produce viable mice through tetraploid complementation. Nature 2009;461:86-90.
10. Yu J, Hu K, Smuga-Otto K et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009;324:797-801.
11. Anokye-Danso F, Trivedi CM, Juhr D et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011;8:376-388.
12. González F, Boué S, Belmonte JCI. Methods for making induced pluripotent stem cells: Reprogramming à la carte. Nat Rev Genet 2011;12:231-242.
13. Jaenisch R. Stem cells, pluripotency and nuclear reprogramming. J Thromb Haemost 2009;7(suppl 1):21-23.
14. Bhutani N, Brady JJ, Damian M et al. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 2010;463:1042-1047.
15. Yamanaka S. Elite and stochastic models for induced pluripotent stem cell generation. Nature 2009;460:49-52.
16. Flöttmann M, Scharp T, Klipp E. A stochastic model of epigenetic dynamics in somatic cell reprogramming. Front Physiol 2012;3:216.
17. Sun N, Longaker MT, Wu JC. Human iPS cell-based therapy: Considerations before clinical applications. Cell Cycle 2010;9:880-885.
18. Stadtfeld M, Maherali N, Breault DT et al. Defining molecular corner-stones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2008;2:230-240.
19. Chan EM, Ratanasirintrawoot S, Park I-H et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 2009;27:1033-1037.
20. Stadtfeld M, Apostolou E, Akutsu H et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 2010;465:175-181.
21. Smith ZD, Nachman I, Regev A et al. Dynamic single-cell imaging of direct reprogramming reveals an early specifying event. Nat Biotechnol 2010;28:521-526.
22. Brambrink T, Foreman R, Welstead GG et al. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2008;2:151-159. (Pubitemid 351168714)
23. Mikkelsen TS, Hanna J, Zhang X et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008;454:49-55. (Pubitemid 351931978)
24. Samavarchi-Tehrani P, Golipour A, David L et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 2010;7:64-77.
25. Alon U. Network motifs: Theory and experimental approaches. Nat Rev Genet 2007;8:450-461. (Pubitemid 46789247)
26. Alon U. An Introduction to Systems Biology: Design Principles of Biological Circuits. Taylor & Francis, 2006. Available at http://books.google.nl/books?id=pAUdPQlCZ54C.
27. Shoval O, Alon U. SnapShot: Network motifs. Cell 2010;143:326-e1.
28. Tyson JJ, Chen KC, Novak B. Sniffers, buzzers, toggles and blinkers: Dynamics of regulatory and signaling pathways in the cell. Curr Opin Cell Biol 2003;15:221-231. (Pubitemid 36332198)
29. Utikal J, Polo JM, Stadtfeld M et al. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 2009;460:1145-1148.
30. Li H, Collado M, Villasante A et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009;460:1136-1139.
31. Ang Y-S, Tsai S-Y, Lee D-F et al. Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell 2011;145:183-197.
32. Pawlak M, Jaenisch R. De novo DNA methylation by Dnmt3a and Dnmt3b is dispensable for nuclear reprogramming of somatic cells to a pluripotent state. Genes Dev 2011;25:1035-1040.
33. Singhal N, Graumann J, Wu G et al. Chromatin-remodeling components of the BAF complex facilitate reprogramming. Cell 2010;141:943-955.
34. Trokovic R, Weltner J, Manninen T et al. Small molecule inhibitors promote efficient generation of induced pluripotent stem cells from human skeletal myoblasts. Stem Cells Dev 2013;1:114-123.
35. Zhang M, Wang F, Kou Z et al. Defective chromatin structure in somatic cell cloned mouse embryos. J Biol Chem 2009;284:24981-24987.
36. Hirai H, Tani T, Katoku-kikyo N et al. Radical accleration of nuclear reprogramming by chromatin remodeling with the transactivation domain of MyoD. Stem Cells 2011;29:1349-1361.
37. Marson A, Foreman R, Chevalier B et al. Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 2008;3:132-135.
38. Yang J, Gao C, Chai L et al. A novel SALL4/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells. PLoS One 2010;5:e10766.
39. Hanna J, Saha K, Pando B et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009;462:595-601.
40. Koche RP, Smith ZD, Adli M et al. Reprogramming factor expression initiates widespread targeted chromatin remodeling. Cell Stem Cell 2011;8:96-105.
41. Creyghton MP, Cheng AW, Welstead GG et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci USA 2010;107:21931-21936.
42. Boyer LA, Lee TI, Cole MF et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005;122:947-956. (Pubitemid 41345211)
43. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 2008;132:567-582. (Pubitemid 351253686)
44. Li R, Liang J, Ni S et al. A Mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 2010;7:51-63.
45. Papapetrou EP, Tomishima MJ, Chambers SM et al. Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc Natl Acad Sci USA 2009;106:12759-12764.
46. Sommer CA, Sommer AG, Longmire TA et al. Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cells 2010;28:64-74.
47. Stadtfeld M, Hochedlinger K. Induced pluripotency: History, mechanisms, and applications. Genes Dev 2010;24:2239-2263.
48. Maherali N, Ahfeldt T, Rigamonti A et al. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 2008;3:340-345.
49. Silva J, Nichols J, Theunissen TW et al. Nanog is the gateway to the pluripotent ground state. Cell 2009;138:722-737.
50. Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 2007;25:1177-1181. (Pubitemid 47538112)
51. Buganim Y, Faddah DA, Cheng AW et al. Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 2012;150:1209-1222.
52. Tchieu J, Kuoy E, Chin MH et al. Female human iPSCs retain an inactive X chromosome. Cell Stem Cell 2010;7:329-342.
53. Tomoda K, Takahashi K, Leung K et al. Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells. Cell Stem Cell 2012;11:91-99.
54. Nichols J, Smith A. Naive and primed pluripotent states. Cell Stem Cell 2009;4:487-492.
55. Hanna J, Cheng AW, Saha K et al. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci USA 2010;107:9222-9227.
56. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676. (Pubitemid 44233629)
57. Marion RM, Strati K, Li H et al. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 2009;4:141-154.
58. Yehezkel S, Rebibo-Sabbah A, Segev Y et al. Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Epigenetics 2011;6:63-75.
59. Bernstein BE, Mikkelsen TS, Xie X et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006;125:315-326.
60. Mikkelsen TS, Ku M, Jaffe DB et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007;448:553-560. (Pubitemid 47206934)
61. Hawkins RD, Hon GC, Lee LK et al. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 2010;6:479-491.
62. Azuara V, Perry P, Sauer S et al. Chromatin signatures of pluripotent cell lines. Nat Cell Biol 2006;8:532-538.
63. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell 2007;128:669-681. (Pubitemid 46273573)
64. Lister R, Pelizzola M, Kida YS et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011;470:68-73.
65. Nishino K, Toyoda M, Yamazaki-Inoue M et al. DNA methylation dynamics in human induced pluripotent stem cells over time. PLoS Genet 2011;7:e1002085.
66. Polo JM, Liu S, Figueroa ME et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 2010;28:848-855.
67. Ghosh Z, Wilson KD, Wu Y et al. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One 2010;5:e8975.
68. Marchetto MCN, Yeo GW, Kainohana O et al. Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One 2009;4:e7076.
69. Chin MH, Mason MJ, Xie W et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009;5:111-123.
70. Guenther MG, Frampton GM, Soldner F et al. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 2010;7:249-257.
71. Kim J, Chu J, Shen X et al. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008;132:1049-1061. (Pubitemid 351381745)
72. Chickarmane V, Troein C, Nuber UA et al. Transcriptional dynamics of the embryonic stem cell switch. PLoS Comput Biol 2006;2:e123.
73. Silva J, Smith A. Capturing pluripotency. Cell 2008;132:532-536. (Pubitemid 351253697)
74. MacArthur BD, Please CP, Oreffo ROC. Stochasticity and the molecular mechanisms of induced pluripotency. PLoS One 2008;3:e3086.
75. Chang HH, Hemberg M, Barahona M et al. Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature 2008;453:544-547. (Pubitemid 351733323)
76. Chambers I, Silva J, Colby D et al. Nanog safeguards pluripotency and mediates germline development. Nature 2007;450:1230-1234.
77. Feng B, Ng J-H, Heng J-CD et al. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 2009;4:301-312.
78. Li W, Ding S. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends Pharmacol Sci 2010;31:36-45.
79. Orkin SH, Hochedlinger K. Chromatin connections to pluripotency and cellular reprogramming. Cell 2011;145:835-850.
80. Zhou H, Wu S, Joo JY et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009;4:381-384.